Northwestern Medicine Integrates Tempus AI’s “David” Clinical Assistant into EHR Platform

Tempus AI Inc. (NASDAQ:TEM) is one of the worst AI stocks to invest in according to financial media. On September 4, Northwestern Medicine and Tempus AI announced an expanded collaboration, making Northwestern Medicine the first health system to integrate David, Tempus’ generative AI-enabled clinical assistant, into its electronic health record/EHR platform.

The partnership will use data and AI to advance patient care to mark a new chapter in a collaboration that began a decade ago. The integration of David will empower Northwestern Medicine’s clinical teams with real-time and AI-enabled insights directly within the EHR.

Northwestern Medicine Integrates Tempus AI's "David" Clinical Assistant into EHR Platform

By adopting core parts of Tempus’ AI infrastructure, Northwestern Medicine will be able to underpin its AI applications with a multimodal patient record. This will allow for the co-development, deployment, and real-time monitoring of new AI algorithms and agents within the David experience. It will enable clinical teams to perform several functions like building custom AI agents, querying patient data using NL, and automating pre-appointment preparation with AI-generated summaries and histories.

Tempus AI Inc. (NASDAQ:TEM) is a healthcare technology company that provides next-gen sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing.

While we acknowledge the potential of TEM to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than TEM and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.